FDA Said It Never Inspected Dental Lab That Made Controversial AGGA Device

The FDA never inspected Johns Dental Laboratories during more than a decade in which it made the Anterior Growth Guidance Appliance, or AGGA, a dental device that has allegedly harmed patients and is now the subject of a criminal investigation.

This story also ran on CBS News. It can be republished for free. More from This InvestigationWhen Medical Devices Malfunction

Americans trust the FDA to make sure medical devices are safe and to act swiftly if problems arise. But a yearlong investigation by KFF Health News revealed that a series of FDA-cleared products, both implanted in the human body and used to treat chronic diseases, have been suspected of contributing to thousands of injuries and patient deaths.Read More

According to FDA documents obtained through the Freedom of Information Act, the agency became aware of the AGGA from a joint investigation by KFF Health News and CBS News in March 2023, then responded with its first-ever inspection of Johns Dental months later.

That inspection found that the Indiana dental device manufacturer didnt require all customer complaints to be investigated and the company did not investigate some complaints about people being hurt by products, including the AGGA, the FDA documents state. The FDA requires device companies to investigate complaints and forward them to the agency. Johns Dental had never alerted the FDA to any such complaints, according to the documents.

The AGGA, which its inventor testified has been used on more than 10,000 patients, was promoted by dentists nationwide, some of whom said it could grow or expand an adults jaw without surgery and treat common ailments like sleep apnea. But these claims were not backed by peer-reviewed research, and Johns Dental has settled lawsuits from 20 patients who alleged the AGGA caused them grievous harm. The company has not admitted liability.

Two former FDA officials said the AGGA was likely able to stay on the market and off the FDAs radar for so long because of the lack of inspections and investigations at Johns Dental. Madris Kinard, a former FDA manager who founded Device Events, which analyzes FDA data, said it defies belief that Johns Dental never received a complaint worthy of relaying to the FDA.

Thats a red flag for me. If I dont see a single report to the FDA, I typically think there is something going on, Kinard said. When they dont report, what you have is devices that stay on the market much longer than they should. And patients get harmed.

Johns Dental Laboratories declined to comment when reached by phone and its lawyers did not respond to requests for an interview. The family-owned company, which has operated since 1939 in the western Indiana city of Terre Haute, sells dozens of products to dentists and makes hundreds of retainers and sleep apnea appliances each month, according to its website.

Twelve of Johns Dentals products are registered with the FDA as Class II medical devices, meaning they carry at least a moderate risk, and some have been featured on the company website for at least two decades, according to screen captures preserved by the Internet Archive. The FDA never inspected Johns Dental Laboratories, in Terre Haute, Indiana, during more than a decade in which the lab made the Anterior Growth Guidance Appliance, or AGGA, according to FDA documents.(Samantha Liss/KFF Health News)

The AGGA, which was invented by Tennessee dentist Steve Galella in the 1990s, was not registered with the FDA like Johns Dentals other devices. Company owner Jerry Neuenschwander has said in sworn court depositions that Johns Dental started making the AGGA in 2012 and became Galellas exclusive manufacturer in 2015 and that at one point the AGGA was responsible for about one-sixth of Johns Dentals total sales revenue.

In another deposition, Johns Dental CEO Lisa Bendixen said the company made about 3,000 to 4,000 AGGAs a year and paid Galellas company a royalty of $50 to $65 for every sale.

“We are not dentists. We do not know how these appliances work. All we do is manufacture to Dr. Galella’s specifications, she said, according to a deposition transcript.

The FDAs lack of knowledge about the AGGA likely contributed to its loose oversight of Johns Dental. When asked to explain the lack of inspection, the FDA said that, based on what it knew at the time, it was not required to inspect Johns Dental until 2018 when the company registered as a contract manufacturer of other medical devices. Prior to 2018, the FDA was only aware of Johns Dental operating as a dental laboratory, which normally do not manufacture their own products and only modify devices made by other companies to fit dentists specifications. The FDA does not regularly inspect dental labs, although it can if it has concerns or gets complaints, the agency said.

Kinard said that based on her experience at the FDA she believes the agency prioritizes medical devices over dental devices, which may have contributed to the lack of inspections at Johns Dental.

There hasnt been much attention to dental devices in the past, Kinard said. Hopefully thats going to change because of dental implant failures, as well as this device, which has quite obviously had serious issues. Email Sign-Up

Subscribe to KFF Health News' free Morning Briefing. Your Email Address Sign Up

The AGGA resembles a retainer and uses springs to apply pressure to the front teeth and upper palate, according to a patent application. Last year, the KFF Health News-CBS News investigation revealed the AGGA was not backed by any peer-reviewed research and had never been submitted to the FDA for review. At the time, at least 20 patients had alleged in lawsuits that the AGGA had caused grievous harm to their teeth, gums, and bone and some said theyd lost teeth. Multiple dental specialists said in interviews that they had examined AGGA patients whose teeth had been shoved out of position by the device, sometimes causing tens of thousands of dollars in damage.

The entire concept of this device, of this treatment, makes zero sense, said Kasey Li, a maxillofacial surgeon who published research on AGGA patients that appeared on a National Institutes of Health website. It doesnt grow the jaw. It doesnt widen the jaw. It just pushes the teeth out of their original position.

Johns Dental and Galella have negotiated out-of-court settlements with the original 20 AGGA plaintiffs without publicly admitting fault. At least 13 more AGGA patients have filed similar lawsuits since the KFF Health News-CBS News investigation. Johns Dental and Galella denied wrongdoing or have not yet responded to the allegations in the newer lawsuits.

Galella declined to be interviewed in 2023 and neither he nor his attorneys responded to recent requests for comment. One of his attorneys, Alan Fumuso, said in a 2023 statement that the AGGA is safe and can achieve beneficial results when used properly. An Anterior Growth Guidance Appliance, or AGGA, is photographed before being used by Karan Gill, who wore the device for months and alleged in a lawsuit his teeth were left loose and sensitive. The AGGAs inventor, Steve Galella, and its manufacturer, Johns Dental Laboratories, settled the lawsuit after denying all liability.(Karan Gill)

In the wake of the KFF Health News-CBS News report, Johns Dental abruptly stopped making the AGGA, according to the newly released FDA documents. The Department of Justice soon after opened a criminal investigation into the AGGA that was ongoing as of December, according to court filings. No charges have been filed. A DOJ spokesperson declined comment.

Spurred by the March 2023 news report, the FDA inspected Johns Dental in July. The FDAs website shows that Johns Dental was issued seven citations, but the substance of the agencys findings was not known until the inspection report was obtained this year.

FDA investigator David Gasparovich wrote in that report that he arrived unannounced at Johns Dental last July and was met by five attorneys who insructed employees not to answer any questions about the AGGA or the companys complaint policies. Neuenschwander was told by his attorney not to talk to the inspector, the report states.

He asked if he could photograph my credentials, Gasparovich wrote in his report. This was the last conversation I would have with Mr. Neuenschwander at the request of his attorney.

The FDA requires device companies to investigate product complaints and submit a medical device report to the agency within 30 days if the products may have contributed to serious injury or death. Gasparovichs inspection report states that Johns Dental had not adequately investigated customer complaints, and its complaint policies were not adequately established, allowing employees to not investigate if the product was not first returned to the company.

Johns Dental received four complaints about the AGGA after the KFF Health News-CBS News report, including one that came after the FDA announced safety concerns about the device, according to the inspection report.

Zero (0) out of the four (4) complaints were investigated, Gasparovich wrote in the report. Each complaint was closed on the same day it was received.

In the months after Gasparovichs inspection, Johns Dental sent letters to the FDA saying it revised its complaint policies to require more investigations and hired a consultant and an auditor to address other FDA concerns, according to the documents obtained through FOIA.

Former FDA analyst M. Jason Brooke, now an attorney who advises medical device companies, said the FDA uses an internal risk-based algorithm to determine when to inspect manufacturers and he advises his clients to expect inspections every three to five years.

Brooke said the AGGA is an example of how the FDAs oversight can be hamstrung by its reliance on device manufacturers to be transparent. If device companies dont report to the agency, it can be left unaware of patient complaints, malfunctions, or even entire products, he said.

When a company doesnt follow the law, Brooke said, the FDA is in the dark.

If there aren’t complaints coming from patients, doctors, competitors, or the company itself, then in a lot of ways, there’s just a dearth of information for the FDA to consume to trigger an inspection, Brooke said.

CBS News producer Nicole Keller contributed to this article.

Brett Kelman:, @BrettKelman Related Topics Health Industry Dental Health FDA Indiana Investigation Tennessee When Medical Devices Malfunction Contact Us Submit a Story Tip

Articles You May Like

Tesla’s Technoking gives lessons on performance reviews
Trump’s Republican allies show their support at ‘hush money’ trial
Robust new-issues led by NYC TFA, SFO airport, NJ turnpike, price into welcoming market
Phoenix airport eyes new terminal among other improvements
El-Erian says Fed’s higher-for-longer rates U-turn is at odds with market